Focus Partners Wealth’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Buy
136,313
+69,504
+104% +$6.38M 0.01% 650
2025
Q4
$6.02M Buy
66,809
+51,521
+337% +$4.89M 0.01% 879
2025
Q3
$1.51M Sell
15,288
-5,964
-28% -$591K ﹤0.01% 1123
2025
Q2
$1.94M Buy
21,252
+4,297
+25% +$415K ﹤0.01% 913
2025
Q1
$1.92M Buy
16,955
+297
+2% +$31.8K ﹤0.01% 854
2024
Q4
$1.76M Buy
16,658
+2,433
+17% +$261K ﹤0.01% 866
2024
Q3
$1.54M Buy
14,225
+5,362
+60% +$585K ﹤0.01% 836
2024
Q2
$962K Buy
8,863
+556
+7% +$65.5K ﹤0.01% 802
2024
Q1
$1.1M Buy
8,307
+2,949
+55% +$368K 0.01% 587
2023
Q4
$652K Buy
+5,358
New +$598K 0.01% 528

Other funds holding ZBH

Focus Partners Wealth's ZBH Position: Q1 2026 in Review

Focus Partners Wealth increased its Zimmer Biomet (ZBH) stake by 104% in Q1 2026, buying an estimated $6.38M and bringing the position to 136,313 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #650.

Focus Partners Wealth first reported a position in ZBH in Q4 2023 and has held it in 10 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Focus Partners Wealth held 136,313 shares of Zimmer Biomet worth $12.3M as of Q1 2026.
  • Focus Partners Wealth bought 69,504 Zimmer Biomet shares in Q1 2026, an estimated $6.38M.
  • Zimmer Biomet made up 0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #650 holding.
  • Focus Partners Wealth first reported a position in Zimmer Biomet in Q4 2023 and has held it in 10 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.